Fitzgerald R L, Blanke R V, Glennon R A, Yousif M Y, Rosecrans J A, Poklis A
Department of Pharmacology and Toxicology, Medical College of Virginia, Richmond 23298.
J Chromatogr. 1989 May 5;490(1):59-69. doi: 10.1016/s0378-4347(00)82761-9.
A method for the determination of the enantiomeric content of 3,4-methylenedioxyamphetamine (MDA) and 3,4-methylenedioxymethamphetamine (MDMA) in microsamples (200 microliters) of whole blood is described. The method involves liquid-liquid extraction of MDA and MDMA from blood and derivatization with the chiral reagent N-trifluoroacetyl-L-prolyl chloride. Separation, identification and quantitation of diastereomeric derivatives is by gas chromatography-mass spectrometry. The analytical range of the assay is from 0.12 ng to 48 ng injected on-column. Details for the synthesis of the enantiomers of MDMA are also provided.
描述了一种测定全血微量样本(200微升)中3,4-亚甲基二氧基苯丙胺(MDA)和3,4-亚甲基二氧基甲基苯丙胺(摇头丸)对映体含量的方法。该方法包括从血液中液-液萃取MDA和摇头丸,并用手性试剂N-三氟乙酰基-L-脯氨酰氯进行衍生化。非对映体衍生物的分离、鉴定和定量通过气相色谱-质谱法进行。该测定的分析范围是柱上进样0.12纳克至48纳克。还提供了摇头丸对映体合成的详细信息。